PT-2021-4667 · Adobe+4 · Xmp Toolkit Sdk+4

Published 2021-08-17 · Updated 2025-08-04 · CVE-2021-36055

Positive Technologies (AI Summary)

CVSS v2.0

9.3

High

Base vector

AV:N/AC:M/Au:N/C:C/I:C/A:C

Name of the Vulnerable Software and Affected Versions XMP Toolkit SDK versions 2020.1 and earlier

Description The issue is related to a use-after-free vulnerability that could result in arbitrary code execution in the context of the current user. Exploitation of this issue requires user interaction, where a victim must open a malicious file. Additionally, it is associated with buffer overflow errors in dynamic memory.

Recommendations For XMP Toolkit SDK versions 2020.1 and earlier, at the moment, there is no information about a newer version that contains a fix for this vulnerability.

Heap Based Buffer Overflow

Use After Free

Weakness Enumeration

CWE-122

CWE-416

Related Identifiers

BDU:2021-05360

CVE-2021-36055

DLA-3585-1

DLA-4264-1

MGASA-2022-0236

USN-5483-1

Affected Products

Astra Linux

Debian

Linuxmint

Ubuntu

Xmp Toolkit Sdk

References · 41

• https://nvd.nist.gov/vuln/detail/CVE-2021-36055 · Security Note
• https://osv.dev/vulnerability/CVE-2021-36055 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-36053 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-36055 · Vendor Advisory
• https://ubuntu.com/security/CVE-2018-12648 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-36050 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-42532 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-42529 · Vendor Advisory
• https://helpx.adobe.com/security/products/xmpcore/apsb21-65.html · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-36054 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-36045 · Vendor Advisory
• https://cve.org/CVERecord?id=CVE-2021-36055 · Security Note
• https://ubuntu.com/security/CVE-2021-42530 · Vendor Advisory
• https://ubuntu.com/security/CVE-2021-42528 · Vendor Advisory
• https://osv.dev/vulnerability/DEBIAN-CVE-2021-36055 · Vendor Advisory